Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
postdialysis redistribution | concentration changes after dialysis as drug moves between body compartments | Postdialysis redistribution was considered when comparing early and later postdialysis draws. | Assessment | Medication response, exposure and reconciliation |
predicted trough | estimated concentration at the end of a future or modeled interval | Distinguish the predicted trough from the actual predose measurement. | Plan | Drug levels - verification and documentation |
random level | concentration collected outside a specified peak or trough schedule | The random level was drawn at 14:20, six hours after the recorded dose. | Objective | Drug levels - collection and dose timing |
repeat level | new concentration from another collection | The repeat level was obtained by separate venipuncture. | Objective | Drug levels - collection and dose timing |
resumption level | concentration measured in relation to restarting an interrupted regimen | The resumption level was interpreted with the date and time therapy resumed. | Assessment | Medication response, exposure and reconciliation |
saturable metabolism | metabolic capacity becomes limiting as concentration rises | The assessment notes possible saturable metabolism when interpreting the phenytoin trend. | Assessment | Drug levels - exposure and pharmacokinetics |
serum level | concentration measured in serum | The serum level is reported in ng/mL on the original result. | Objective | Drug levels - analyte, specimen and reporting |
sirolimus | mTOR inhibitor monitored using whole-blood concentrations in specified settings | The sirolimus report states whole blood and the collection time. | Objective | Drug levels - named analytes and exposure reports |
specific gravity | urine concentration compared with water | Urine specific gravity is 1.025. | Objective | Blood count, chemistry and urine findings |
steady state | repeated dosing produces a reproducible concentration pattern each interval | Whether steady state was reached is uncertain after the recent regimen change. | Assessment | Drug levels - exposure and pharmacokinetics |
target trough | goal specified for a properly timed predose concentration | The target trough in the current protocol differs from the earlier target. | Assessment | Drug levels - exposure and pharmacokinetics |
terminal elimination slope | slope of the final log-linear portion of the concentration curve | The terminal elimination slope was estimated from the selected late samples. | Assessment | Drug concentrations, exposure and assay interpretation |
terminal half-life | time for concentration to halve during the terminal log-linear phase | The report gives a terminal half-life based on the final sampling interval. | Assessment | Drug concentrations, exposure and assay interpretation |
therapeutic drug monitoring | interpretation of timed drug concentrations in clinical context | Request pharmacy input for therapeutic drug monitoring after the regimen change. | Plan | Drug levels - verification and documentation |
therapeutic range | concentration interval used as a treatment reference for a specified context | The applicable therapeutic range depends on the drug, specimen, timing and indication. | Assessment | Drug levels - exposure and pharmacokinetics |
thyroglobulin level | concentration of a protein made by thyroid follicular cells | The thyroglobulin level was interpreted with thyroid history and antibody status. | Objective | Glucose monitoring, endocrine testing and urine studies |
time above threshold | duration during which concentration exceeds a specified value | The estimate of time above threshold used the threshold named in the pharmacokinetic report. | Assessment | Drug concentrations, exposure and assay interpretation |
timed level | concentration obtained at a documented offset from administration | The timed level was obtained eight hours after the observed dose. | Objective | Drug levels - collection and dose timing |
| time at which the maximum concentration occurs | The report gives an estimated Tmax for the oral formulation. | Assessment | Drug levels - exposure and pharmacokinetics | |
topiramate | antiseizure medicine with a measurable blood concentration | The outside topiramate report includes the collection date and assay units. | Objective | Drug levels - named analytes and exposure reports |
trough-to-dose ratio | trough concentration divided by the stated dose | The service documented the dose convention used for the trough-to-dose ratio. | Assessment | Drug concentrations, exposure and assay interpretation |
unbound-to-total ratio | free concentration divided by total concentration in comparable samples | The unbound-to-total ratio was interpreted only after checking that both results used compatible units. | Assessment | Medication response, exposure and reconciliation |
volume of distribution | apparent volume relating amount in the body to measured concentration | The model's volume of distribution is reported with its units. | Assessment | Drug levels - exposure and pharmacokinetics |
whole-blood level | concentration measured in whole blood | The tacrolimus whole-blood level is listed with the assay method. | Objective | Drug levels - analyte, specimen and reporting |
absolute bioavailability | systemic availability relative to an intravenous reference with dose adjustment | The study estimated absolute bioavailability using paired oral and intravenous data. | Assessment | Drug concentrations, exposure and assay interpretation |